, 63, 565-5711 have reported an increase in the urinary excretion of 6-0x0-prostaglandin F,, (6-oxo-PGFlJ during intravenous infusion of safflower oil (Liposyn) [l] . The authors have attributed this finding to increased prostacyclin (PGI,) production, and suggest that such infusions may prove to be of therapeutic benefit. The authors have carefully considered several alternative explanations. However, they do not report the concentration of serum nonesterified fatty acids (NEFA). This measurement may be of relevance to the interpretation of their fmdings, since:
(1) We have previously shown that the half-life of the biological activity of PGI, in vitro is prolonged in human plasma [2] and in solutions of fatty acid-free human albumin [3] . We have also shown that the presence of increasingly higher amounts of NEFA in fatty acid-free human albumin solutions results in a progressive shortening of the biological half-life of added PGI, [4] . The unsaturated fatty acids, linoleic and linolenic, were more potent than the saturated fatty acids, palmitic and stearic (unpublished observations).
Furthermore, we have shown that the amount of fatty acids bound to albumin is relevant, a high fatty acid content being associated with less PGIrstabilizing potential [3, 51. Therefore, elevated serum NEFA concentration during the Liposyn infusion would shorten the half-life of PGI, in the circulation. This in turn may enhance the rate of formation and excretion of 6-0x0-PGF,, (the stable, spontaneous metabolite of (2) We have previously shown that a progressive increase in the concentrations of NEFA added to rat aortic rings results in an increasing inhibition of PGI, synthesis in vitro (as measured by the conversion of labelled arachidonic acid into 6-oxo-PGFlJ [6] . In this system, the unsaturated fatty acids, linoleic and linolenic, were the most potent inhibitors of the conversion of arachidonate into 6-oxo-PGFl,. Therefore, an elevation in the serum NEFA concentration during the Lipo-PGIZ).
syn infusion would be expected to result in inhibition of PGIz synthesis, rather than in stimulation.
(3) There is evidence that platelets are activated in the presence of high NEFA concentrations [7- 151. An elevation in serum NEFA concentrations during the Liposyn infusion and any associated platelet activation could potentially neutralize the benefits of increased production of PGI,. Platelet activation may itself accelerate the production of thromboxane A, (TXA,, a potent stimulator of platelet aggregation and a vasoconstrictor) and also result in the release of vasoactive compounds (e.g. serotonin), which, in turn, may influence renal clearance of 6-oxo-PGFl,. Furthermore, linoleic acid contained in safflower oil may act as a substrate for TXA2 synthesis, as discussed by Epstein et al. [ 11. Therefore an elevated fatty acid concentration may alter the synthesis, turnover and excretion of PGI, and its metabolites at different sites. Any interpretation of data related to the excretion of 6-oxo-PGF1, must take these facts into consideration. 499-500.
